Beverly M. Biller, MD, PhD

Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• ORF28-05 - Effect of CAM2029 on Long-Term Biochemical and Symptom Control in Patients with Acromegaly and IGF-I ≤2×ULN According to Prior Injectable Somatostatin Receptor Ligand Dose: Results from ACROINNOVA 2

  Sunday, June 14, 2026
  2:15 PM - 2:30 PM CT

• ORF28-06 - Efficacy and Safety of Once-Daily Oral Paltusotine in Patients with Acromegaly: Up to 2 Years in the PATHFNDR-1 and PATHFNDR-2 Open-Label Extension Studies

  Sunday, June 14, 2026
  2:30 PM - 2:45 PM CT

• ORF35-03 - Osilodrostat Improves Health-Related Quality of Life in Cushing's Disease: Analysis of Patient-Reported Outcomes from the Phase III LINC 3 and LINC 4 Studies

  Sunday, June 14, 2026
  3:40 PM - 3:45 PM CT